Gene interactions and pathways from curated databases and text-mining

◀ Back to NOS1

AGTR1 — NOS1

Text-mined interactions from Literome

Roczniak et al., J Am Soc Nephrol 1999 (Disease Models, Animal) : Losartan treatment was used to determine the role of angiotensin II ( AngII ) AT1 receptors in the inhibition of nNOS expression in 5/6 Nx. Losartan had no effect on the decreased expression of nNOS in the inner medulla, but partially increased nNOS protein expression in the cortex of 5/6 Nx rats
Qadri et al., Jpn J Pharmacol 2001 : Angiotensin converting enzyme inhibitors and AT1-receptor antagonist restore nitric oxide synthase (NOS) activity and neuronal NOS expression in the adrenal glands of spontaneously hypertensive rats
Kiss et al., Endocr Regul 2001 : Changes in angiotensin AT1 receptor mRNA levels in the rat brain after immobilization stress and inhibition of central nitric oxide synthase
Andersen et al., Am J Physiol Regul Integr Comp Physiol 2002 : Volume expansion increased arterial pressure significantly in all series involving this procedure, most pronounced during combined AT(1) blockade and NOS inhibition ( 21 +/- 4 mmHg ) ... Volume expansion during AT(1) blockade increased GFR ( +30 % ), less so during combined AT(1) blockade and NOS inhibition ( +13 % ), but it did not increase GFR significantly ( P = 0.07 ) during NOS inhibition alone
Wang et al., Physiol Res 2007 : Role of brain angiotensin AT1 receptor in the carbachol induced natriuresis and expression of nNOS in the locus coeruleus and proximal convoluted tubule
Suzuki et al., Endocrinology 2006 (Hypertrophy) : Activation of endothelial nitric oxide synthase by the angiotensin II type 1 receptor
Dong et al., J Pharmacol Exp Ther 2011 (Hypertension...) : High-salt loading in SHRSPs caused the reduction of cerebral blood flow (CBF), cerebral hypoxia, white matter lesions, glial activation, AT1 receptor up-regulation, endothelial nitric-oxide synthase (eNOS) uncoupling, inducible nitric-oxide synthase induction , and nitroxidative stress
Sharma et al., Cardiovasc Res 2011 (Chronic Disease...) : Identifying this crucial nNOS/CAPON interaction regulated by AT(1) receptors may provide an important potential therapeutic target in CHF
Sharma et al., Am J Physiol Cell Physiol 2012 : Specific inhibition of nNOS , using antisense, caused an increase in AT(1)R expression while overexpression of nNOS, using adenoviral gene transfer ( Ad.nNOS ), caused an inhibition of AT(1)R expression in NG108 cells
Nakayama et al., Blood Press Suppl 1994 : Angiotensin II type 1 receptor mediated inhibition of cytokine stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells